Cargando…
Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the underlying immune mechanisms accounting for acc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402834/ https://www.ncbi.nlm.nih.gov/pubmed/34452314 http://dx.doi.org/10.3390/v13081448 |
_version_ | 1783745886339203072 |
---|---|
author | Grubczak, Kamil Grzeszczuk, Anna Groth, Monika Hryniewicz, Anna Kretowska-Grunwald, Anna Flisiak, Robert Moniuszko, Marcin |
author_facet | Grubczak, Kamil Grzeszczuk, Anna Groth, Monika Hryniewicz, Anna Kretowska-Grunwald, Anna Flisiak, Robert Moniuszko, Marcin |
author_sort | Grubczak, Kamil |
collection | PubMed |
description | Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the underlying immune mechanisms accounting for accelerated disease progression in HIV/HCV-coinfected individuals have not been described in sufficient detail. We hypothesized that regulatory T cells (Treg) bearing potent immunosuppressive capacities could not only play a substantial role in the pathogenesis of HCV/HIV coinfection but also modulate the response to the standard anti-viral therapy. Materials and Methods: To this end, we studied alterations in frequencies of Treg cells in correlation with other Treg-related and virus-related parameters in both HCV and HCV/HIV-infected patients subjected to standard pegIFN-α/RBV therapy. Results: Notably, we found that pegIFN-α/RBV therapy significantly increased levels of Treg cells in HCV-infected but not in HIV/HCV-coinfected individuals. Furthermore, HIV/HCV-coinfection was demonstrated to inhibit expansion of regulatory T cells during anti-viral treatment; thus, it might probably be responsible for viral persistence and HCV-related liver damage. Conclusions: Therapy with pegIFN-α/RBV demonstrated a significant effect on regulatory T cells in the course of HIV and/or HCV infection indicating a crucial role in the anti-viral immune response. |
format | Online Article Text |
id | pubmed-8402834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84028342021-08-29 Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients Grubczak, Kamil Grzeszczuk, Anna Groth, Monika Hryniewicz, Anna Kretowska-Grunwald, Anna Flisiak, Robert Moniuszko, Marcin Viruses Article Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, the underlying immune mechanisms accounting for accelerated disease progression in HIV/HCV-coinfected individuals have not been described in sufficient detail. We hypothesized that regulatory T cells (Treg) bearing potent immunosuppressive capacities could not only play a substantial role in the pathogenesis of HCV/HIV coinfection but also modulate the response to the standard anti-viral therapy. Materials and Methods: To this end, we studied alterations in frequencies of Treg cells in correlation with other Treg-related and virus-related parameters in both HCV and HCV/HIV-infected patients subjected to standard pegIFN-α/RBV therapy. Results: Notably, we found that pegIFN-α/RBV therapy significantly increased levels of Treg cells in HCV-infected but not in HIV/HCV-coinfected individuals. Furthermore, HIV/HCV-coinfection was demonstrated to inhibit expansion of regulatory T cells during anti-viral treatment; thus, it might probably be responsible for viral persistence and HCV-related liver damage. Conclusions: Therapy with pegIFN-α/RBV demonstrated a significant effect on regulatory T cells in the course of HIV and/or HCV infection indicating a crucial role in the anti-viral immune response. MDPI 2021-07-25 /pmc/articles/PMC8402834/ /pubmed/34452314 http://dx.doi.org/10.3390/v13081448 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Grubczak, Kamil Grzeszczuk, Anna Groth, Monika Hryniewicz, Anna Kretowska-Grunwald, Anna Flisiak, Robert Moniuszko, Marcin Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title | Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title_full | Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title_fullStr | Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title_full_unstemmed | Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title_short | Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients |
title_sort | effects of pegylated interferon alpha and ribavirin (pegifn-α/rbv) therapeutic approach on regulatory t cells in hcv-monoinfected and hcv/hiv-coinfected patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402834/ https://www.ncbi.nlm.nih.gov/pubmed/34452314 http://dx.doi.org/10.3390/v13081448 |
work_keys_str_mv | AT grubczakkamil effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT grzeszczukanna effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT grothmonika effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT hryniewiczanna effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT kretowskagrunwaldanna effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT flisiakrobert effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients AT moniuszkomarcin effectsofpegylatedinterferonalphaandribavirinpegifnarbvtherapeuticapproachonregulatorytcellsinhcvmonoinfectedandhcvhivcoinfectedpatients |